Efficacy and Safety of Apatinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: An Open-Label, Single-Arm, Prospective Study

被引：0
|
作者：
Ma, Xinran [1 ]
Li, Ling [1 ]
Zhang, Lei [1 ]
Li, Xin [1 ]
Fu, Xiaorui [1 ]
Wang, Xinhua [1 ]
Wu, Jingjing [1 ]
Zhang, Xudong [1 ]
Feng, Xiaoyan [1 ]
Zhou, Zhiyuan [1 ]
Chang, Yu [1 ]
Li, Zhaoming [1 ]
Young, Ken H. [2 ]
Zhang, Mingzhi [1 ]
机构：
[1] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127912
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2873
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Pirtobrutinib in Chinese patients with relapsed or refractory B-cell malignancies: A single-arm, open-label, phase 2, multicenter trial
    Liu, Yanyan
    Lin, Ningjing
    Yi, Shuhua
    Huang, Huiqiang
    Guo, Ye
    Zhang, Qingyuan
    Yang, Haiyan
    Zhang, Huilai
    Zhang, Liling
    Feng, Ru
    Qian, Yijiao
    Zhu, Jiankun
    Song, Yuqin
    Zhu, Jun
    INTERNATIONAL JOURNAL OF CANCER, 2025,
  • [32] Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/TCell Lymphoma: A Prospective, Single-Arm, Open-Label, Multi-Center, Phase. Clinical Trial
    Gao, Yan
    Huang, Huiqiang
    Wang, Xiaoxiao
    Bai, Bing
    Huang, Yunhong
    Yang, Haiyan
    Zhang, QingYuan
    Li, Yufu
    Li, Yan
    Zhou, Min
    Yang, Runxiang
    Xu, Bing
    Liu, Lihong
    Yang, Yu
    Peng, Zhigang
    Yu, Ding
    Zhou, Hui
    Zhang, Rong Yan
    Zhang, Huilai
    Qi, Junyuan
    Xi, Yaming
    Xing, Xiaojing
    Wang, Zhao
    Jing, Hongmei
    Zhang, Xiaohong
    Ma, Liping
    Jin, Hongyan
    Yao, Hongxia
    Shuang, Yuerong
    Xia, Xuefang
    Xue, Jianfei
    Li, Chunlei
    BLOOD, 2020, 136
  • [33] An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
    Van Cutsem, E.
    Siena, S.
    Humblet, Y.
    Canon, J. -L.
    Maurel, J.
    Bajetta, E.
    Neyns, B.
    Kotasek, D.
    Santoro, A.
    Scheithauer, W.
    Spadafora, S.
    Amado, R. G.
    Hogan, N.
    Peeters, M.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 92 - 98
  • [34] Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study
    Li, Ling
    Kong, Fei
    Zhang, Lei
    Li, Xin
    Fu, Xiaorui
    Wang, Xinhua
    Wu, Jingjing
    Zhang, Fangwen
    Ren, Liangliang
    Zhang, Mingzhi
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (06) : 1847 - 1853
  • [35] Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study
    Ling Li
    Fei Kong
    Lei Zhang
    Xin Li
    Xiaorui Fu
    Xinhua Wang
    Jingjing Wu
    Fangwen Zhang
    Liangliang Ren
    Mingzhi Zhang
    Investigational New Drugs, 2020, 38 : 1847 - 1853
  • [36] Efficacy and safety blinatumomab in chinese adults with Ph-negative relapsed/refractory B-cell Precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational study
    Zhou, Hongsheng
    Yin, Qingsong
    Jin, Jie
    Liu, Ting
    Cai, Zhen
    Jiang, Bin
    Li, Dengju
    Sun, Zimin
    Li, Yan
    He, Yanjuan
    Ma, Liping
    Gao, Sujun
    Hu, Jianda
    He, Aili
    Du, Xin
    Liu, Daihong
    Zhang, Xiaohong
    Ke, Xiaoyan
    Zhuang, Junling
    Han, Yue
    Wang, Xiaoqin
    Chen, Yuqi
    Gordon, Paul
    Yu, Dong
    Zugmaier, Gerhard
    Wang, Jianxiang
    HEMATOLOGY, 2022, 27 (01) : 917 - 927
  • [37] A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma
    Cassaday, Ryan D.
    Goy, Andre
    Advani, Suresh
    Chawla, Purvi
    Nachankar, Rajesh
    Gandhi, Mansi
    Gopal, Ajay K.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (07): : 392 - 397
  • [38] An open-label, single-arm phase II study of everolimus (RAD001) in patients with relapsed/refractory classical Hodgkin lymphoma (HL)
    Johnston, P. B.
    Lewis, L. T.
    Rogerio, J. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Linperlisib in Conjunction with Gemcitabine and Oxaliplatin in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Multicenter, Single-Arm Phase Ib/II Study
    Li, Zhiming
    Sun, Peng
    Cen, Hong
    Yang, Haiyan
    Huang, Rui
    Cai, Zhen
    Gu, Xuekui
    BLOOD, 2023, 142
  • [40] An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma or Follicular Lymphoma
    Younes, Anas
    Salles, Gilles
    Bociek, R. Gregory
    Martinelli, Giovanni
    Caballero, Dolores
    Gonzalez Barca, Eva
    Mukherjee, Nabanita
    Williams, Lisa
    Herbst, Fabian
    Tavorath, Ranjana
    Kim, Won Seog
    BLOOD, 2014, 124 (21)
12345